ADMA Biologics, Inc. Engages KPMG LLP as New Independent Registered Public Accounting Firm

ADMA Biologics, Inc. (NASDAQ: ADMA) entered into an agreement with KPMG LLP on October 31, 2024, detailing KPMG’s role as the company’s new independent registered public accounting firm. The effective date of this engagement will coincide with the filing of ADMA Biologics’ Quarterly Report on Form 10-Q for the fiscal quarter ending September 30, 2024. […]

Leave a Reply

Your email address will not be published.

Previous post **Stronghold Digital Mining Enters Hosting Agreement with Backbone Mining Solutions**
Next post William Blair Analysts Lower Earnings Estimates for PayPal